| abstract |
The present invention relates to the use of eletriptan, or a pharmaceutically acceptable salt or composition thereof, for the manufacture of a medicament for the prevention of migraine recurrence, and to a method for the manufacture of a dual, sustained, delayed, controlled or pulsatile release pharmaceutical composition for the prevention of migraine recurrence Lt; / RTI > receptor agonists, or a pharmaceutically acceptable salt or composition thereof, for use as a medicament. |